Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity

被引：0
|
作者：
E D Warlick
Q Cao
J Miller
机构：
[1] Oncology,Division of Hematology
[2] and Transplantation,undefined
[3] University of Minnesota Medical School,undefined
[4] Biostatistics and Informatics,undefined
[5] Masonic Cancer Center,undefined
[6] University of Minnesota,undefined
来源：
Leukemia | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1789 / 1791
页数：2
相关论文
共 50 条
  • [31] Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes
    Prebet, Thomas
    Braun, Thorsten
    Beyne-Rauzy, Odile
    Dreyfus, Francois
    Stammatoullas, Aspasia
    Wattel, Eric
    Ame, Shanti
    Raffoux, Emmanuel
    Delaunay, Jacques
    Charbonnier, Aude
    Ades, Lionel
    Fenaux, Pierre
    Vey, Norbert
    LEUKEMIA RESEARCH, 2014, 38 (01) : 29 - 33
  • [32] Hematopoietic Cell Transplantation in High-Risk Childhood Acute Myelogenous Leukemia
    Meshinchi, Soheil
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1002 - 1003
  • [33] A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes
    F Locke
    R Agarwal
    R Kunnavakkam
    K van Besien
    R A Larson
    O Odenike
    L A Godley
    H Liu
    M M Le Beau
    S Gurbuxani
    M J Thirman
    D Sipkins
    C White
    A Artz
    W Stock
    Bone Marrow Transplantation, 2013, 48 : 1437 - 1443
  • [34] A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes
    Locke, F.
    Agarwal, R.
    Kunnavakkam, R.
    van Besien, K.
    Larson, R. A.
    Odenike, O.
    Godley, L. A.
    Liu, H.
    Le Beau, M. M.
    Gurbuxani, S.
    Thirman, M. J.
    Sipkins, D.
    White, C.
    Artz, A.
    Stock, W.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1437 - 1443
  • [35] Prognostic role of immunophenotyping in acute myeloid leukemia and high risk Myelodysplastic Syndromes
    Fadda, M. R.
    Norata, M.
    Calvaruso, G.
    Caramazza, D.
    Palazzolo, R.
    Abbadessa, V
    Mitra, M. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 75 - 75
  • [36] Intensive treatment in patients with high-risk myelodysplastic syndromes and secondary acute leukaemia
    Bargay, J
    Brunet, S
    Esteve, J
    Ribera, J
    Ribera, J
    Llorente, A
    Marti, J
    Sarrà, J
    Guardia, R
    Pedro, C
    Nomdedeu, B
    Sierra, J
    Besalduch, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S256 - S256
  • [37] Gender Differences in Quality of Life of Patients with Acute Myeloid Leukemia and High-risk Myelodysplastic Syndromes Receiving Treatment
    Tinsley, Sara
    Padron, Eric
    Lengacher, Cecile
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S216 - S216
  • [38] Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes
    Izutsu, Koji
    Ubukawa, Kumi
    Morishita, Takanobu
    Onishi, Yasushi
    Ishizawa, Kenichi
    Fujii, Yosuke
    Kimura, Nobuyuki
    Yokochi, Miyuu
    Naoe, Tomoki
    CANCER SCIENCE, 2024, 115 (04) : 1250 - 1260
  • [39] Baseline Serum Ferritin Predicts Rate of Infection in Patients with Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome.
    Mattiuzzi, Gloria
    Amin, Hesham M.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    BLOOD, 2009, 114 (22) : 644 - 644
  • [40] Deep DNA Sequencing Identifies Small Mutations in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Analysis of Intratumor Genomic Heterogeneity for Prediction of Disease Relapse
    Kritharis, Athena
    Kaur, Sukhdeep
    Loh, Jui Wan
    Hadigol, Mohammad
    Khiabanian, Hossein
    Strair, Roger
    BLOOD, 2019, 134
12345